Brief: Cero Therapeutics Hearing Review Council Issued Decision
03/02/2026 23:23
Feb 3 (Reuters) - CERo Therapeutics Holdings Inc CERO.PK: CERO THERAPEUTICS: HEARING REVIEW COUNCIL ISSUED DECISION AFFIRMING NASDAQ HEARING PANEL'S DECISION TO DELIST COMPANY’S SECURITIES FROM NASDAQ Source text: [ID:n0001213900-26-011587] Further company coverage: CERO.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List